id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0388-0002,FDA,FDA-2007-N-0388,Supporting Statement - Request for OMB Review,Supporting & Related Material,Statement (Supporting and Related Material),2007-10-17T04:00:00Z,2007,10,,,2025-07-01T23:43:34Z,,0,0,090000648042d7b5
FDA-2007-N-0388-0004,FDA,FDA-2007-N-0388,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Toll-Free Number for Consumer
Reporting of Drug Product Side Effects: Comprehension",Notice,Notice of Approval,2007-10-17T04:00:00Z,2007,10,,,2025-07-01T23:39:15Z,E7-20075,0,0,090000648042d7b8
FDA-2007-N-0388-0003,FDA,FDA-2007-N-0388,Supporting Statement - Toll-Free Number for Consumer Reporting of Drug Product Side Effects: Comprehension Experiment,Supporting & Related Material,Statement (Supporting and Related Material),2007-10-17T04:00:00Z,2007,10,,,2025-07-01T23:47:39Z,,0,0,090000648042d7b6
FDA-2007-N-0388-0001,FDA,FDA-2007-N-0388,"Agency Emergency Processing Under Office of Management and Budget Review; Toll-Free Number for Reportlng Adverse Events on Labeling for
Human Drug Products; Labellng Comprehension Study",Notice,30 Day Proposed Information Collection,2007-02-07T05:00:00Z,2007,2,,,2025-07-01T23:32:17Z,,0,0,090000648042d7b2